From PEG to randomized PEG: a macromolecular strategy tackling PEG immunogenicity.
PEGylation is a crucial strategy in modern nanomedicine, offering effective and safer therapeutics. However, the growing prevalence of anti-PEG antibodies (APAs) in patients has raised critical concerns, with multiple studies demonstrating reduced clinical efficacy and safety risks associated with APA formation. This h...